Association of the Serotonin Receptor 3E Gene As a Functional Variant in the MicroRNA-510 Target Site with Diarrhea Predominant Irritable Bowel Syndrome in Chinese Women
Overview
Affiliations
Background/aims: The functional variant (rs56109847) in the 3'-untranslated regions (3'-UTR) of the serotonin receptor 3E (HTR3E) gene is associated with female diarrhea predominant irritable bowel syndrome (IBS-D) in British populations. However, the relationship of the polymorphism both to HTR3E expression in the intestine and to the occurrence of Chinese functional gastrointestinal disorders has yet to be examined.
Methods: Polymerase chain reaction amplification and restriction fragment length polymorphism analyses were employed to detect polymorphisms among Chinese Han women, particularly 107 patients with IBS-D, 99 patients with functional dyspepsia (FD), 115 patients with mixed IBS and 69 patients with IBS-D + FD. We also assessed microRNA-510 (miR-510) and HTR3Eexpression in human colonic mucosal tissues with immunohistochemistry and other methods. Dual-luciferase reporter assays were conducted to examine the binding ability of miR-510 and HTR3E 3'-UTR.
Results: Genotyping data showed the variant rs56109847 was significantly associated with IBS-D, but not with FD, mixed-IBS, or FD + IBS-D. HTR3E was abundantly expressed around the colonic mucosal glands but less expressed in the stroma. miR-510 expression decreased, whereas HTR3E expression increased in the colonic mucosal tissue of patients with IBS-D compared with those in controls. HTR3E expression was significantly higher in patients with the GA genotype than that in patients with the GG genotype. The single-nucleotide polymorphisms disrupted the binding site of miR-510 and significantly upregulated luciferase expression in HEK293 and HT-29 cells.
Conclusions: The single-nucleotide polymorphisms rs56109847 led to reduced microRNA binding and overexpression of the target gene in intestinal cells, thereby increasing IBS-D risk in the Chinese Han population. The decreased expression of miR-510 might contribute to IBS-D.
Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism.
Camilleri M, Jencks K Expert Opin Drug Metab Toxicol. 2024; 20(5):319-332.
PMID: 38785066 PMC: 11139426. DOI: 10.1080/17425255.2024.2349716.
Berberine Enhances Intestinal Mucosal Barrier Function by Promoting Vitamin D Receptor Activity.
Huang Y, Liu J, Chen G, Shen D, Zhu W, Chen X Chin J Integr Med. 2023; 30(2):143-151.
PMID: 37046128 DOI: 10.1007/s11655-023-3547-x.
The serotonin receptor 3E variant is a risk factor for female IBS-D.
Fritz N, Berens S, Dong Y, Martinez C, Schmitteckert S, Houghton L J Mol Med (Berl). 2022; 100(11):1617-1627.
PMID: 36121467 PMC: 9592668. DOI: 10.1007/s00109-022-02244-w.
Bravo-Vazquez L, Medina-Rios I, Marquez-Gallardo L, Reyes-Munoz J, Serrano-Cano F, Pathak S Dig Dis Sci. 2022; 68(1):38-53.
PMID: 35507132 PMC: 9066399. DOI: 10.1007/s10620-022-07516-6.
Peng Z, Liu X, Cheng Z, Kai W, Song Z Ann Transl Med. 2021; 9(20):1576.
PMID: 34790782 PMC: 8576727. DOI: 10.21037/atm-21-4756.